Pulse Biosciences, Inc. (PLSE) Tops Q4 EPS by 7c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $264 thousand versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Viking Holdings Ltd (VIK) Tops Q2 EPS by 36c
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts